The Hematologist

July August 2011 Vol 8 Issue 4

July-August 2011, Volume 8, Issue 4

Features

  • ASH Helps to Build Capacity for Cytogenetics Laboratories in MexicoJuly 01, 2011 | LoAnn Peterson, MD

    In April, medical professionals from the United States and Mexico met in Mexico City to kick off a pilot program designed to standardize cytogenetics laboratory procedures for the diagnosis of hematologic malignancies in Mexico. This meeting came about after AMEH (La Agrupación Mexicana para el Estudio la Hematología [the Mexican hematology association]) asked ASH to help investigate ways to build capacity for hematologic cytogenetics laboratories in Mexico.

back to top

Diffusion

back to top

Mini Review

  • The Cancer-Thrombosis ConnectionJuly 01, 2011 | Anna Falanga, MD

    The Cancer Thrombosis ConnectionDivision of Immunohematology and Tranfusion Medicine, Department of Oncology Hematology, Ospedali Riuniti, Bergamo, Italy  Dr. Falanga serves on a Virtual Advisory Board for Pfizer and as part of the Registry Master Oncology at Sanofi Aventis.  The close

back to top

Clinical Trials Corner

  • Sequelae of DVT: Post-Thrombotic SyndromeJuly 01, 2011 | Gregory M. Vercellotti, MD

    The purpose of this study is to determine if the use of adjunctive PCDT, which includes the intrathrombus administration of rt-PA, can prevent PTS in patients with symptomatic proximal DVT as compared with optimal standard DVT therapy alone.

  • SIPPET Slowly: This One's HOT!July 01, 2011

    This is a prospective trial designed to compare inhibitor incidence in previously untreated patients or minimally blood-component-treated patients with hemophilia exposed to plasma-derived vWF/FVIII or recombinant FVIII products.

back to top

Profiles

  • Alvin Mauer, MD (1928-2011)July 01, 2011

    Alvin Mauer, MD, former president of the American Society of Hematology, died May 26, 2010, at the age of 82. Work by this distinguished physician, researcher, and mentor advanced the fields of hematology and oncology.

  • Hillbilly HematologistJuly 01, 2011 | José A. López, MD

    Hillbilly HematologistExecutive Vice President for Research, Puget Sound Blood Center  My journey to hematology and blood research has been the result of a series of chance occurrences. I grew up in Peñasco, a small village at an elevation of 8,000

  • Joel M. Rappeport, MD (1939 - 2011)July 01, 2011

    Joel Rappeport, MD, died on January 16, 2011, after a long illness. He was an internationally recognized expert in bone marrow failure and hematopoietic stem cell transplantation.

back to top

President's Column

  • Catalyzing Careers in Clinical Hematology ResearchJuly 01, 2011 | J. Evan Sadler, MD, PhD

    Catalyzing Careers in Clinical Hematology ResearchThe American Society of Hematology Agenda for Hematology Research (2009 2011) highlights several scientific areas that have a great deal of potential for groundbreaking insights, including hematopoietic stem cells, hematopoiesis, sickle cell disease, hematologic malignancies,

back to top

Op-Ed

  • Hematology Private Practice is Bleeding to DeathJuly 01, 2011 | Thomas A. Bensinger, MD

    Community-based private hematology practices are a valuable resource for the care and treatment of many patients with hematologic problems. Unfortunately, hematologists have recently seen a rapid increase in what had been a slow erosion of the incentives to enter and remain in such practices.

back to top

News and Reports

  • ASH Capitol Hill Days Focus on Funding for Research and Preventing Drug ShortagesJuly 01, 2011

    At the end of March, as Washington was in the midst of a budgetary showdown and preparing for a possible shutdown of the federal government, members of the ASH Committee on Government Affairs made visits to Capitol Hill to explain to Members of Congress and their staff the impact of proposed cuts in funding to the National Institutes of Health (NIH) on research to find cures and treatments for patients with serious hematologic diseases.

back to top